118 related articles for article (PubMed ID: 20467347)
1. Upregulated histone deacetylase 1 expression in pancreatic ductal adenocarcinoma and specific siRNA inhibits the growth of cancer cells.
Gao DJ; Xu M; Zhang YQ; Du YQ; Gao J; Gong YF; Man XH; Wu HY; Jin J; Xu GM; Li ZS
Pancreas; 2010 Oct; 39(7):994-1001. PubMed ID: 20467347
[TBL] [Abstract][Full Text] [Related]
2. The kinase Mirk/Dyrk1B mediates cell survival in pancreatic ductal adenocarcinoma.
Deng X; Ewton DZ; Li S; Naqvi A; Mercer SE; Landas S; Friedman E
Cancer Res; 2006 Apr; 66(8):4149-58. PubMed ID: 16618736
[TBL] [Abstract][Full Text] [Related]
3. Significance of DNA methyltransferase-1 and histone deacetylase-1 in pancreatic cancer.
Wang W; Gao J; Man XH; Li ZS; Gong YF
Oncol Rep; 2009 Jun; 21(6):1439-47. PubMed ID: 19424621
[TBL] [Abstract][Full Text] [Related]
4. Use of IHC and newly designed matriptase inhibitors to elucidate the role of matriptase in pancreatic ductal adenocarcinoma.
Uhland K; Siphos B; Arkona C; Schuster M; Petri B; Steinmetzer P; Mueller F; Schweinitz A; Steinmetzer T; Van De Locht A
Int J Oncol; 2009 Aug; 35(2):347-57. PubMed ID: 19578749
[TBL] [Abstract][Full Text] [Related]
5. Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.
Xue A; Xue M; Jackson C; Smith RC
Int J Biochem Cell Biol; 2009; 41(8-9):1731-8. PubMed ID: 19433314
[TBL] [Abstract][Full Text] [Related]
6. BGLAP is expressed in pancreatic cancer cells and increases their growth and invasion.
Kayed H; Bekasi S; Keleg S; Michalski CW; Giese T; Friess H; Kleeff J
Mol Cancer; 2007 Dec; 6():83. PubMed ID: 18163903
[TBL] [Abstract][Full Text] [Related]
7. Human pancreatic ribonuclease 1: expression and distribution in pancreatic adenocarcinoma.
Peracaula R; Cleary KR; Lorenzo J; de Llorens R; Frazier ML
Cancer; 2000 Sep; 89(6):1252-8. PubMed ID: 11002220
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma.
Nitori N; Ino Y; Nakanishi Y; Yamada T; Honda K; Yanagihara K; Kosuge T; Kanai Y; Kitajima M; Hirohashi S
Clin Cancer Res; 2005 Apr; 11(7):2531-9. PubMed ID: 15814630
[TBL] [Abstract][Full Text] [Related]
9. Heat shock protein 70 increases tumorigenicity and inhibits apoptosis in pancreatic adenocarcinoma.
Aghdassi A; Phillips P; Dudeja V; Dhaulakhandi D; Sharif R; Dawra R; Lerch MM; Saluja A
Cancer Res; 2007 Jan; 67(2):616-25. PubMed ID: 17234771
[TBL] [Abstract][Full Text] [Related]
10. Key role of phosphoinositide 3-kinase class IB in pancreatic cancer.
Edling CE; Selvaggi F; Buus R; Maffucci T; Di Sebastiano P; Friess H; Innocenti P; Kocher HM; Falasca M
Clin Cancer Res; 2010 Oct; 16(20):4928-37. PubMed ID: 20876794
[TBL] [Abstract][Full Text] [Related]
11. [Expression of annexin I in human pancreatic cancer and the influence of its down-regulation on biology of this cancer].
Liu Q; Wang CF; Zhou Z; Hu H; Zhao DB; Ni XG; Bai XF; Gao JD; Tian YT; Zhao P
Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):738-41. PubMed ID: 18396684
[TBL] [Abstract][Full Text] [Related]
12. Epithelial MMP-2 expression correlates with worse prognosis in pancreatic cancer.
Juuti A; Lundin J; Nordling S; Louhimo J; Haglund C
Oncology; 2006; 71(1-2):61-8. PubMed ID: 17377415
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of growth factors and the urokinase-type plasminogen activator system in pancreatic ductal adenocarcinoma.
Xue A; Scarlett CJ; Jackson CJ; Allen BJ; Smith RC
Pancreas; 2008 Mar; 36(2):160-7. PubMed ID: 18376307
[TBL] [Abstract][Full Text] [Related]
14. Invasive intraductal papillary-mucinous neoplasm of the pancreas: comparison with pancreatic ductal adenocarcinoma.
Murakami Y; Uemura K; Sudo T; Hayashidani Y; Hashimoto Y; Nakashima A; Sueda T
J Surg Oncol; 2009 Jul; 100(1):13-8. PubMed ID: 19384908
[TBL] [Abstract][Full Text] [Related]
15. [The role of matrix metalloproteinases in pancreatic ductal adenocarcinoma].
Tsyganov SE; Paklina OV; Setdikova GR; Shabunin AV; Bedin VV; Tavobilov MM; Nikitin PN
Arkh Patol; 2012; 74(1):16-8. PubMed ID: 22712298
[TBL] [Abstract][Full Text] [Related]
16. Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells.
Zhao S; Venkatasubbarao K; Li S; Freeman JW
Cancer Res; 2003 May; 63(10):2624-30. PubMed ID: 12750289
[TBL] [Abstract][Full Text] [Related]
17. Adenoviral-mediated gene transfer of Gadd45a results in suppression by inducing apoptosis and cell cycle arrest in pancreatic cancer cell.
Li Y; Qian H; Li X; Wang H; Yu J; Liu Y; Zhang X; Liang X; Fu M; Zhan Q; Lin C
J Gene Med; 2009 Jan; 11(1):3-13. PubMed ID: 19003803
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic ductal carcinoma: from the bench to the bedside.
Pezzilli R
JOP; 2006 Sep; 7(5):508-10. PubMed ID: 16998251
[No Abstract] [Full Text] [Related]
19. Overexpression and elevated serum levels of phosphoglycerate kinase 1 in pancreatic ductal adenocarcinoma.
Hwang TL; Liang Y; Chien KY; Yu JS
Proteomics; 2006 Apr; 6(7):2259-72. PubMed ID: 16493704
[TBL] [Abstract][Full Text] [Related]
20. Enhanced expression of 14-3-3sigma in pancreatic cancer and its role in cell cycle regulation and apoptosis.
Guweidhi A; Kleeff J; Giese N; El Fitori J; Ketterer K; Giese T; Büchler MW; Korc M; Friess H
Carcinogenesis; 2004 Sep; 25(9):1575-85. PubMed ID: 15073049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
